Pneumonia

Community-acquired pneumonia in children: what to do when there is no response to standard empirical treatment?
Shivanthan Shanthikumar, Amelia Clifford, John Massie, Theresa Cole, Andrew Steer, Michael Marks, Amanda Gwee

Thorax Oct 2016, 71 (10) 957-959; DOI: 10.1136/thoraxjnl-2016-208787
Respiratory mortality of childhood, adolescent and young adult cancer survivors
Miranda M Fidler, Raoul C Reulen, Chloe J Bright, Katherine E Henson, Julie S Kelly, Meriel Jenney, Antony Ng, Jeremy Whelan, David L Winter, Clare Frobisher, Michael M Hawkins

Thorax Oct 2018, 73 (10) 959-968; DOI: 10.1136/thoraxjnl-2017-210683
Nox2 up-regulation is associated with an enhanced risk of atrial fibrillation in patients with pneumonia
Francesco Violi, Roberto Carnevale, Camilla Calvieri, Cristina Nocella, Marco Falcone, Alessio Farcomeni, Gloria Taliani, Roberto Cangemi, in collaboration with the SIXTUS study group

Thorax Oct 2015, 70 (10) 961-966; DOI: 10.1136/thoraxjnl-2015-207178
The use of benzodiazepines could be a protective factor for community-acquired pneumonia (CAP) in ≤60-year-old subjects
Jordi Almirall, Mateu Serra-Prat, Francisco Baron, Elisabet Palomera, Ignasi Bolíbar

Thorax Oct 2013, 68 (10) 964-965; DOI: 10.1136/thoraxjnl-2013-203634
Authors’ response to Almirall et al
Robert D Sanders

Thorax Oct 2013, 68 (10) 965-966; DOI: 10.1136/thoraxjnl-2013-203701
Nanotechnology based therapeutics for lung disease
Mohammad Doroudian, Ronan MacLoughlin, Fergus Poynton, Adriele Prina-Mello, Seamas C Donnelly

Thorax Oct 2019, 74 (10) 965-976; DOI: 10.1136/thoraxjnl-2019-213037
Severe respiratory viral infection induces procalcitonin in the absence of bacterial pneumonia
Samir Gautam, Avi J Cohen, Yannick Stahl, Patricia Valda Toro, Grant M Young, Rupak Datta, Xiting Yan, Nicholas T Ristic, Santos D Bermejo, Lokesh Sharma, Marcos I Restrepo, Charles S Dela Cruz

Thorax Nov 2020, 75 (11) 974-981; DOI: 10.1136/thoraxjnl-2020-214896
Mortality of CAP reduced in the UK: is this enough?
Antoni Torres, Carolina Garcia-Vidal

Thorax Nov 2016, 71 (11) 979-980; DOI: 10.1136/thoraxjnl-2016-209284
Which individuals are at increased risk of pneumococcal disease and why? Impact of COPD, asthma, smoking, diabetes, and/or chronic heart disease on community-acquired pneumonia and invasive pneumococcal disease
Antoni Torres, Francesco Blasi, Nathalie Dartois, Murat Akova

Thorax Oct 2015, 70 (10) 984-989; DOI: 10.1136/thoraxjnl-2015-206780
Pneumonia classification and healthcare-associated pneumonia: a new avenue or just a cul-de-sac?
Mark Woodhead

Thorax Nov 2013, 68 (11) 985-986; DOI: 10.1136/thoraxjnl-2013-204060

Main menu

Pneumonia

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Pneumonia

Pages